{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:43:37Z","timestamp":1790685817439,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":715,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.jacc.2011.05.028","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T17:47:08Z","timestamp":1314121628000},"page":"1025-1033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Homocysteine and Reclassification of Cardiovascular Disease Risk"],"prefix":"10.1016","volume":"58","author":[{"given":"Vikas","family":"Veeranna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip K.","family":"Zalawadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Niraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotiranjan","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ference","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Burack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sony","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.05.028_bib1","first-page":"e21","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.05.028_bib2","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.05.028_bib3","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1056\/NEJMe0801721","article-title":"Multiple biomarker panels for cardiovascular risk assessment","volume":"358","author":"de Lemos","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib4","doi-asserted-by":"crossref","first-page":"28A","DOI":"10.1016\/j.amjcard.2005.11.013","article-title":"Current and future directions of cardiovascular risk prediction","volume":"9","author":"Smith","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.05.028_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-151-7-200910060-00010","article-title":"Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force","volume":"151","author":"Helfand","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCOUTCOMES.108.831198","article-title":"C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study","volume":"1","author":"Wilson","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2011.05.028_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2011.05.028_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.291.2.210","article-title":"Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals","volume":"291","author":"Greenland","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.05.028_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion","volume":"50","author":"Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2011.05.028_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archinte.165.2.138","article-title":"In search of fewer independent risk factors","volume":"165","author":"Brotman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2011.05.028_bib12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.STR.0000142374.33919.92","article-title":"Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study","volume":"35","author":"Sacco","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2011.05.028_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1253\/circj.CJ-08-1077","article-title":"Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese","volume":"73","author":"Sun","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2011.05.028_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.STR.0000060203.58958.35","article-title":"Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease","volume":"34","author":"Tanne","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2011.05.028_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-ethnic study of atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2011.05.028_bib16","series-title":"Multi-Ethnic Study of Atherosclerosis Field Center Manual of Operations","year":"2001"},{"key":"10.1016\/j.jacc.2011.05.028_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","article-title":"Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"422","author":"Araki","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jacc.2011.05.028_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1515\/CCLM.2004.041","article-title":"Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer","volume":"42","author":"Lonati","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib22","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.05.028_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the Multi-Ethnic Study of Atherosclerosis","volume":"120","author":"Yeboah","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.05.028_bib26","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.281.19.1817","article-title":"Homocysteine and risk of cardiovascular disease among postmenopausal women","volume":"281","author":"Ridker","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.05.028_bib27","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.05.028_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4065\/81.2.177","article-title":"Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk","volume":"81","author":"Kullo","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2011.05.028_bib29","doi-asserted-by":"crossref","first-page":"a3083","DOI":"10.1136\/bmj.a3083","article-title":"Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study","volume":"338","author":"de Ruijter","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2011.05.028_bib30","series-title":"Screening for Intermediate Risk Factors for Coronary Heart Disease: Systematic Evidence Synthesis","author":"Helfand","year":"2009"},{"key":"10.1016\/j.jacc.2011.05.028_bib31","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.05.028_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10545-010-9151-1","article-title":"The homocysteine controversy","volume":"34","author":"Smulders","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.jacc.2011.05.028_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006612.pub2","article-title":"Homocysteine lowering interventions for preventing cardiovascular events","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2011.05.028_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjcard.2010.03.064","article-title":"Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels","volume":"106","author":"Miller","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.05.028_bib35","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"303","author":"Armitage","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.05.028_bib36","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.05.028_bib38","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.ehj.2003.08.012","article-title":"Global risk assessment for cardiovascular disease and astute clinical judgement","volume":"24","author":"Hennekens","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.05.028_bib39","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.05.028_bib40","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711021632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711021632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:46:13Z","timestamp":1760013973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109711021632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0735109711021632"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.05.028","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and Reclassification of Cardiovascular Disease Risk","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}